vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and LiveRamp Holdings, Inc. (RAMP). Click either name above to swap in a different company.
LiveRamp Holdings, Inc. is the larger business by last-quarter revenue ($212.2M vs $208.9M, roughly 1.0× iRhythm Holdings, Inc.). LiveRamp Holdings, Inc. runs the higher net margin — 18.8% vs 2.7%, a 16.1% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 8.6%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 11.1%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
LiveRamp Holdings, Inc., is an American SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
IRTC vs RAMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $212.2M |
| Net Profit | $5.6M | $39.9M |
| Gross Margin | 70.9% | 71.9% |
| Operating Margin | 1.1% | 18.6% |
| Net Margin | 2.7% | 18.8% |
| Revenue YoY | 27.1% | 8.6% |
| Net Profit YoY | 518.5% | 255.7% |
| EPS (diluted) | $0.18 | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $212.2M | ||
| Q3 25 | $192.9M | $199.8M | ||
| Q2 25 | $186.7M | $194.8M | ||
| Q1 25 | $158.7M | $188.7M | ||
| Q4 24 | $164.3M | $195.4M | ||
| Q3 24 | $147.5M | $185.5M | ||
| Q2 24 | $148.0M | $176.0M | ||
| Q1 24 | $131.9M | $171.9M |
| Q4 25 | $5.6M | $39.9M | ||
| Q3 25 | $-5.2M | $27.4M | ||
| Q2 25 | $-14.2M | $7.7M | ||
| Q1 25 | $-30.7M | $-6.3M | ||
| Q4 24 | $-1.3M | $11.2M | ||
| Q3 24 | $-46.2M | $1.7M | ||
| Q2 24 | $-20.1M | $-7.5M | ||
| Q1 24 | $-45.7M | $-5.4M |
| Q4 25 | 70.9% | 71.9% | ||
| Q3 25 | 71.1% | 70.2% | ||
| Q2 25 | 71.2% | 70.1% | ||
| Q1 25 | 68.8% | 69.3% | ||
| Q4 24 | 70.0% | 71.9% | ||
| Q3 24 | 68.8% | 72.4% | ||
| Q2 24 | 69.9% | 70.6% | ||
| Q1 24 | 66.3% | 72.2% |
| Q4 25 | 1.1% | 18.6% | ||
| Q3 25 | -4.4% | 10.7% | ||
| Q2 25 | -10.0% | 3.7% | ||
| Q1 25 | -20.5% | -6.1% | ||
| Q4 24 | -2.5% | 7.5% | ||
| Q3 24 | -34.1% | 4.0% | ||
| Q2 24 | -15.5% | -3.0% | ||
| Q1 24 | -28.9% | -8.3% |
| Q4 25 | 2.7% | 18.8% | ||
| Q3 25 | -2.7% | 13.7% | ||
| Q2 25 | -7.6% | 4.0% | ||
| Q1 25 | -19.3% | -3.3% | ||
| Q4 24 | -0.8% | 5.7% | ||
| Q3 24 | -31.3% | 0.9% | ||
| Q2 24 | -13.6% | -4.3% | ||
| Q1 24 | -34.6% | -3.1% |
| Q4 25 | $0.18 | $0.62 | ||
| Q3 25 | $-0.16 | $0.42 | ||
| Q2 25 | $-0.44 | $0.12 | ||
| Q1 25 | $-0.97 | $-0.10 | ||
| Q4 24 | $-0.03 | $0.17 | ||
| Q3 24 | $-1.48 | $0.03 | ||
| Q2 24 | $-0.65 | $-0.11 | ||
| Q1 24 | $-1.47 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $403.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $962.3M |
| Total Assets | $1.0B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $403.4M | ||
| Q3 25 | $565.2M | $376.9M | ||
| Q2 25 | $545.5M | $371.1M | ||
| Q1 25 | $520.6M | $420.8M | ||
| Q4 24 | $535.6M | $384.3M | ||
| Q3 24 | $522.0M | $348.4M | ||
| Q2 24 | $561.5M | $342.7M | ||
| Q1 24 | $569.1M | $368.9M |
| Q4 25 | $152.7M | $962.3M | ||
| Q3 25 | $121.9M | $943.8M | ||
| Q2 25 | $103.7M | $947.8M | ||
| Q1 25 | $86.7M | $948.9M | ||
| Q4 24 | $90.9M | $957.7M | ||
| Q3 24 | $71.8M | $932.1M | ||
| Q2 24 | $99.2M | $951.9M | ||
| Q1 24 | $90.3M | $949.1M |
| Q4 25 | $1.0B | $1.3B | ||
| Q3 25 | $995.2M | $1.2B | ||
| Q2 25 | $964.0M | $1.2B | ||
| Q1 25 | $926.1M | $1.3B | ||
| Q4 24 | $931.4M | $1.3B | ||
| Q3 24 | $909.7M | $1.2B | ||
| Q2 24 | $919.2M | $1.2B | ||
| Q1 24 | $909.8M | $1.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | — |
| Free Cash FlowOCF − Capex | $14.5M | — |
| FCF MarginFCF / Revenue | 6.9% | — |
| Capex IntensityCapex / Revenue | 5.6% | 0.1% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | — | ||
| Q3 25 | $34.9M | $57.4M | ||
| Q2 25 | $27.7M | $-15.8M | ||
| Q1 25 | $-7.9M | — | ||
| Q4 24 | $19.2M | $45.1M | ||
| Q3 24 | $24.3M | $55.6M | ||
| Q2 24 | $11.8M | $-9.3M | ||
| Q1 24 | $-52.0M | — |
| Q4 25 | $14.5M | — | ||
| Q3 25 | $20.1M | $56.8M | ||
| Q2 25 | $17.3M | $-16.2M | ||
| Q1 25 | $-17.3M | — | ||
| Q4 24 | $12.4M | $44.8M | ||
| Q3 24 | $15.5M | $55.4M | ||
| Q2 24 | $3.4M | $-9.6M | ||
| Q1 24 | $-61.8M | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 10.4% | 28.4% | ||
| Q2 25 | 9.3% | -8.3% | ||
| Q1 25 | -10.9% | — | ||
| Q4 24 | 7.5% | 22.9% | ||
| Q3 24 | 10.5% | 29.8% | ||
| Q2 24 | 2.3% | -5.4% | ||
| Q1 24 | -46.8% | — |
| Q4 25 | 5.6% | 0.1% | ||
| Q3 25 | 7.7% | 0.3% | ||
| Q2 25 | 5.6% | 0.2% | ||
| Q1 25 | 5.9% | 0.2% | ||
| Q4 24 | 4.2% | 0.1% | ||
| Q3 24 | 6.0% | 0.1% | ||
| Q2 24 | 5.7% | 0.1% | ||
| Q1 24 | 7.4% | 1.0% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
RAMP
Segment breakdown not available.
